Free Shipping on all domestic orders over $50 (we also offer free local delivery on orders over $25)

Cannabidiol: Barriers to Research and Potential Medical Benefits

National Institute of Health

Recently, the National Institute on Drug Abuse (NIH) issued a letter to the Senate Caucus on International Drug Control discussing the potential benefits of Cannabidiol (CBD) and the current “barriers to research.”  the following is an excerpt from that letter:

"Rigorous clinical studies are still needed to evaluate the clinical potential of CBD for specific conditions. However, pre-clinical research (including both cell culture and animal models) has shown CBD to have a range of effects that may be therapeutically useful, including anti-seizure, antioxidant, neuroprotective, anti-inflammatory, analgesic, anti-tumor, anti-psychotic, and anti-anxiety properties"

More research needs to be done; it should be in the Federal Government’s best interest to facilitate further studies and research of CBD and it’s potential benefits.

You can read the full article here:

Leave a comment

Please note, comments must be approved before they are published